Phytohemagglutinin-induced lymphocyte deoxyribonucleic acid synthesis, dermal hypersensitivity, and peripheral blood thymus-derived lymphocyte numbers were assessed in nine men with experimentally induced rubella infection. Five of these men and two additional volunteers received treatment with tilorone dihydrochloride, an antiviral drug. Response to phytohemagglutinin was not changed during rubella; T lymphocyte numbers in peripheral blood were not influenced by the viral illness. However, dermai hypersensitivity was markedly impaired in all volunteers during the height of the illness. Tilorone alone, or with rubella, had no effect on any of the parameters studied.
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The effect of rubella virus infection on cellmediated immunity (CMI) has been probed most extensively in children with congenital rubella. Lymphocytes from these children show a diminished response to in vitro stimulation with nonspecific mitogens and specific antigens; dermal reactivity to various antigens remains normal (15, 16, 24) . However, these children are a unique population with regard to viral persistence, and findings in this group may not necessarily be applieable to the normal population (3) . With the exception of Debre and Papp's findings that three of eight children with rubella had transient anergy to tuberculin (2), little is known about the effect of rubella infection on the cellular immune system in the normal person. Several recent studies have documented a depression of skin test reactivity and in vitro lymphocyte function during vaccination with attenuated rubella virus (10, 12) . However, Lalla et al. were unable to confirm these findings (9) . The present report documents the effect of experimentally induced rubella infection on several parameters of CMI in humans. In addition, the combined effects of rubella and treatment with an antiviral agent, tilorone f2, 7- Intradermal skin tests were performed with 7 U of streptokinase-streptodornase (Lederle, Inc., Pearl River, N.Y.). Results were read by one observer and were considered positive if induration greater than 10 mm was present at 48 h. Thymus-derived (T) lymphocytes were determined by spontaneous red blood cell (E) rosette formation by the method of Jondal et al. (7) . In vitro lymphocyte response to phytohemagglutinin (PHA) was assessed by a semimicro method modified from that of Fernald (4 
RESULTS
All men inoculated with rubella irrespective of the presence of the antiviral drug developed four-fold or greater rises in hemagglutination inhibition antibody to rubella. All manifested clinical illness, characterized by fever, malaise, myalgia, lymphadenopathy, and rash. The height of the illness was from days 15 to 17. The five men given tilorone had slightly milder clinical illness than those not receiving this agent (19) .
Skin test reactivity was diminished markedly in all persons during the height of the illness, irrespective of whether tilorone had been given (Fig. 1) . Six of nine men had completely negative skin tests on day 16, and the other three had a decrement ranging from 18-to 68-mm induration during the illness. The two controls given tilorone alone had no change in dermal reactivity.
The number of T lymphocytes measured by E rosette formation was not changed during rubella infection (Table 1) . Maximal response to PHA was not diminished during the period of viremia (day 12) or during the height of the illness (day 16) in persons given rubella alone or rubella plus tilorone (Fig. 2) . Dose response curves with PHA also were not altered in the infected or the infected and treated volunteers. The two controls given tilorone alone had no alteration in PHA response.
The antiviral agent tilorone appeared to have no effect on dermal hypersensitivity, PHA response, or T cell numbers in the controls given the drug alone or in the volunteers given both rubella and tilorone. , rubella alone; --, rubella and tilorone; *, tilorone alone. Prechallenge skin test results were available for only three out of nine men. in humans (14, 18) . However, few patients with rubella have been studied (2) . Most interest has focused on CMI in children with persistent rubella infection acquired in utero (15, 16, 24 which have been associated with depressed CMI in humans (5, 8, 22) . Viremia occurs from 2 to 7 days prior to the development of the rash in rubella, and the virus can be recovered from leukocytes during this phase of the illness (20) .
Our studies in experimentally induced rubella have shown a transient mild defect in CMI at the height of the illness. The most marked abnormality was the depression of skin test reactivity. Six of nine persons demonstrated a complete loss of dermal hypersensitivity to streptokinase-streptodornase, and three showed a marked decrease in the amount of induration. Although there was a clear-cut change in skin test responsiveness, rubella infection did not appear to influence the in vitro lymphocyte proliferative response to PHA. E rosette-forming T lymphocytes were not reduced during rubella. This is in accord with the findings of Aiuti et al., who studied a variety of viral illnesses (1). However, these results differ from those of Wybran (25) and Niklassen (13) , who studied a few cases of unspecified viral illness. Differences in technique for the detecting of E rosettes or differences in the viral diseases studied may explain these discrepancies.
These 
